- Ensuring Supply
- Overview: Ensuring Supply
- What Blood Products are Supplied - National Product List
- Supply Planning and Management
- Changes to National Product List
- Contracts with Suppliers
- Supply to Australians Overseas
- Risk Management
- Inventory Management
- Australian Health Provider Blood and Blood Products Charter
- Best Practice
- National Standard
- Case Studies
- Pathology Queensland Case Study
- Hunter Area Pathology Service Case Study
- SAN Pathology Case Study
- BloodMove Project Case Study
- BloodMove Platelets - Case Study
- Burnside War Memorial Hospital Case Study
- The Royal Children's Hospital Melbourne Extended Life Plasma Protocol Case Study
- Preoperative Anaemia Identification, Assessment and Management Case Study
- Point of Care Coagulation Testing Case Study
- Liverpool Hospital RFID Case Study
- Stewardship
- Patient Blood Management
- Immunoglobulin Products
- National Immunoglobulin Governance Program
- National Policy: Immunoglobulin
- National Immunoglobulin Governance Committees
- National Immunoglobulin Governance Program Performance Improvement Strategy 2019-2022
- Criteria for the Clinical Use of Intravenous Immunoglobulin in Australia
- Version 3 of the Criteria!
- Ig Governance Criteria and Progress Updates
- Access to Intravenous Immunoglobulin (IVIg)
- Access to Subcutaneous Immunoglobulin (SCIg)
- Access to Normal Human Immunoglobulin (NHIg)
- BloodSTAR
- BloodSTAR Privacy Controls
- Patient factsheets and resources
- Review of the Authorisation and Clinical Governance Framework for Intravenous Immunoglobulin (2012)
- Ig HTA Reviews
- Anti-D
- Fresh Blood Products
- Bleeding Disorders
- Education and Training
- Adverse Events
- Blood Systems
- Overview: Blood Systems
- Blood Operations Centre
- Australian Bleeding Disorders Registry
- Big Red
- BloodNet
- BloodPortal
- Jurisdictional Reporting
- MyABDR
- Barcode Specifications
- BloodSTAR
- Data & Research
- About Blood
- Publications & Tools
Key links
Site information
Share this page
